Application 210745

Type
NDA
Sponsor
AMGEN INC

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001OTEZLA XRAPREMILASTTABLET, EXTENDED RELEASE;ORAL75MGYesYes
002OTEZLAAPREMILASTTABLET;ORAL10MGNoNo
003OTEZLAAPREMILASTTABLET;ORAL20MGNoNo
005OTEZLAAPREMILASTTABLET;ORAL30MGNoNo

Documents

DocumentSubmission typeDate
84037ORIG 2025-11-03
84015ORIG 2025-11-03
83268ORIG 2025-09-03
83267ORIG 2025-09-03
83251ORIG 2025-09-02
83250ORIG 2025-08-29